Current advances in understanding and managing secondary brain metastasis (Q38233076)

31 August 2017

title

Current advances in understanding and managing secondary brain metastasis (English)

1 reference

31 August 2017

Radhika Dasararaju

1

1 reference

31 August 2017

Amitkumar Mehta

series ordinal

2

1 reference

31 August 2017

publication date

1 January 2013

1 reference

31 August 2017

1 reference

31 August 2017

volume

2

1 reference

31 August 2017

issue

1

1 reference

31 August 2017

page(s)

75-85

1 reference

Resectable brain metastases

31 August 2017

cites work

1 reference

Breast cancer brain metastases

21 January 2018

1 reference

Brain metastases from an unknown primary tumour: which diagnostic procedures are indicated?

21 January 2018

1 reference

Prognosis in patients presenting with brain metastasis from an undiagnosed primary tumor

21 January 2018

1 reference

The molecular biology of brain metastasis

21 January 2018

1 reference

Mechanisms of tumor-related brain edema

21 January 2018

1 reference

21 January 2018

1 reference

Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

21 January 2018

1 reference

Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis

21 January 2018

1 reference

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

Emerging molecular mechanisms of brain tumour oedema.

21 January 2018

1 reference

Platelet-activating factor and edema surrounding meningiomas

21 January 2018

1 reference

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases

21 January 2018

1 reference

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

21 January 2018

1 reference

Long-term survival in patients with brain metastases

21 January 2018

1 reference

Radiosurgery Followed by Planned Observation in Patients with One to Three Brain Metastases

21 January 2018

1 reference

Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline

21 January 2018

1 reference

A randomized trial of surgery in the treatment of single metastases to the brain

21 January 2018

1 reference

RPA classification has prognostic significance for surgically resected single brain metastasis

21 January 2018

1 reference

Surgical resection and permanent iodine-125 brachytherapy for brain metastases

21 January 2018

1 reference

Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience

21 January 2018

1 reference

Fluorescence-guided surgery of metastatic brain tumors using fluorescein sodium

21 January 2018

1 reference

Surgical technique for a cystic-type metastatic brain tumor: transformation to a solid-type tumor using hydrofiber dressing

21 January 2018

1 reference

Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function

21 January 2018

1 reference

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the radiation therapy oncology group (RTOG) 9104

21 January 2018

1 reference

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study

21 January 2018

1 reference

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

21 January 2018

1 reference

Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases

21 January 2018

1 reference

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.

21 January 2018

1 reference

Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor

21 January 2018

1 reference

Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells

21 January 2018

1 reference

A reassessment of vascular endothelial growth factor in central nervous system pathology

21 January 2018

1 reference

Dexamethasone pre-treatment interferes with apoptotic death in glioma cells.

21 January 2018

1 reference

Medical management of patients with brain tumors

21 January 2018

1 reference

Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15.

21 January 2018

1 reference

A phase I trial of human corticotropin-releasing factor (hCRF) in patients with peritumoral brain edema

21 January 2018

1 reference

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity

21 January 2018

1 reference

The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline

21 January 2018

1 reference

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

21 January 2018

1 reference

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

21 January 2018

1 reference

The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism

21 January 2018

1 reference

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

21 January 2018

1 reference

ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas

21 January 2018

1 reference

Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective study

21 January 2018

1 reference

Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers

21 January 2018

1 reference

Therapy of venous thromboembolism in patients with brain metastases

21 January 2018

1 reference

Management of venous thromboembolism in patients with primary and metastatic brain tumors

21 January 2018

1 reference

Treatment of established thrombotic events in patients with cancer

21 January 2018

1 reference

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

Thromboembolism in brain tumors

21 January 2018

1 reference

Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control

21 January 2018

1 reference

Prevention of thromboembolism after neurosurgery for brain and spinal tumors

21 January 2018

1 reference

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.

21 January 2018

1 reference

Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis

21 January 2018

1 reference

Chemotherapy and cerebral metastases: misperception or reality?

21 January 2018

1 reference

The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

21 January 2018

1 reference

Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis

21 January 2018

1 reference

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

21 January 2018

1 reference

Blood-brain barrier integrity and breast cancer metastasis to the brain

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6169476

A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6169476

Thrombosis in cancer patients

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6169476

Vena caval filters: a comprehensive review.

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6169476

Neovasculature induced by vascular endothelial growth factor is fenestrated.

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6169476

Brain metastases. Histology, multiplicity, surgery, and survival

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6169476

Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6169476

Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors. Anticoagulants or inferior vena cava filter?

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6169476

Intracranial Hemorrhage During Systemic Anticoagulation in Patients With Cerebral Metastasis

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6169476

Prostaglandin and thromboxane synthesis by human intracranial tumors.

5 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6169476

Distribution of brain metastases

5 November 2018

1 reference

12 December 2020

Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397)

1 reference

12 December 2020

Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis

1 reference

12 December 2020

Leptomeningeal metastasis

1 reference

12 December 2020

Identifiers

DOI

10.2217/CNS.12.33

1 reference

31 August 2017

0 references

1 reference